Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Mark Ricciardi Added: 9 months ago
HFSA Congress 2024 - Dr Mark Ricciardi (NorthShore Cardiovascular Institute, US) joins us to discuss the findings from the EXPANDed real-world clinical trial on mitral transcatheter edge-to-edge repair with the MitraClip System.The study is designed to confirm the safety and performance of the MitraClip NTR and XTR Systems in mTEER procedures. 1000 patients across 60 sites in Europe and the US… View more
Author(s): Ankeet Bhatt Added: 1 month ago
ESC HF 25 - Secondary analysis of the FINEARTS-HF study shows finerenone treatment favourably influenced the risk of early heart failure readmission.Dr Ankeet Bhatt (Kaiser Permanante San Francisco Medical Center, San Francisco, US) discusses findings from the prespecified secondary analysis of the FINEARTS-HF trial (NCT04435626; Bayer). The placebo-controlled primary analysis investigated the… View more
Author(s): Tomohiro Kaneko Added: 1 month ago
EuroPCR 25 - Real-world registry findings show transcatheter edge-to-edge repair (TEER) is associated with improved prognosis in patients with atrial functional mitral regurgitation (AFMR).We are joined by Dr Tomohiro Kaneko (Juntendo University Graduate School of Medicine, Tokyo, JP) to discuss outcomes from a retrospective cohort study analysing data from two large-scale Japanese registries,… View more
Author(s): Firas Zahr Added: 8 months ago
TCT Conference 24 - Two-year outcomes of CLASP IID shows that the Edwards PASCAL system was noninferior to the Abbott Mitraclip system in transcatheter mitral valve repair for mitral regurgitation.Dr Firas Zahr (Oregon Health and Science University, US) joins us onsite at TCT Conference to discuss the outcomes from the CLASP IID 2 Year RCT and Registry (NCT02371512; Edwards Lifesciences).CLASP… View more
Author(s): Stephan Baldus Added: 8 months ago
TCT Conference 2024 - Clinical outcomes between percutaneous mitral valve repair (PMVR) and mitral valve surgery in patients with atrial mitral regurgitation (MR).Dr Stephan Baldus (University of Köln Medical Center, DE) joins us onsite at TCT Conference to discuss the findings from MATTERHORN (NCT02371512; University of Köln).MATTERHORN is a multicenter, randomized controlled clinical trial,… View more
Author(s): Nicolas M Van Mieghem , Joost Daemen Added: 11 months ago
Which interventional cardiology studies will have the greatest impact at ESC 2024?Leading experts Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) offer an exclusive preview of the most anticipated hot line studies set to be unveiled at ESC Congress 2024. Get their in-depth analysis of the studies and gain invaluable insights ahead of the curve.ESC Congress… View more
Author(s): , Added: 1 year ago
In this series of short interviews and discussions filmed at AV Valves Summit 2023, the faculty delve into sharing invaluable insights and expert opinion on transcathetermitral and tricuspid intervention. They examine a range of topics which include the development of TEER, the importance of quality of life, repair vs replacement and how to best shape the future of MR and TR treatment. The AV… View more